Clinical Trial: A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia
Brief Summary: Multicenter, multinational study to collect consistent baseline growth measurements on pediatric patients with Achondroplasia being considered for subsequent enrollment in Study 111-202. No study drug is administered.
Detailed Summary:
Sponsor: BioMarin Pharmaceutical
Current Primary Outcome: Collection of consistent growth measurements [ Time Frame: Assessed every 3 months for up to 60 months ]
Original Primary Outcome: Collection of consistent growth measurements [ Time Frame: Assessed every 3 months for up to 36 months ]
Current Secondary Outcome:
Original Secondary Outcome:
Information By: BioMarin Pharmaceutical
Dates:
Date Received: May 11, 2012
Date Started: April 2012
Date Completion: November 2017
Last Updated: April 26, 2016
Last Verified: April 2016